Larazotide eased symptoms in phase II celiac trial

CHICAGO – Larazotide acetate, a first-in-class oral medication developed specifically to treat celiac disease, reduced both gastrointestinal and non-GI symptoms in patients who were symptomatic...

Field of Interest: Gastroentero...
Type: News Item

PCPs all over the map in conservative OA therapy use

PARIS – Use of conservative, nonpharmacologic osteoarthritis therapies was relatively low and varied considerably across 10 primary care clinics within the same U.S. health care system. In seven of...

Field of Interest: Geriatrics
Type: News Item

PCPs all over the map in conservative OA therapy use

PARIS – Use of conservative, nonpharmacologic osteoarthritis therapies was relatively low and varied considerably across 10 primary care clinics within the same U.S. health care system. In seven of...

Field of Interest: Rheumatology
Type: News Item

Negative moods tied to OA pain flares

PARIS – Patients with knee osteoarthritis are significantly more likely to experience a flare if they report a higher negative mood in the previous 10 days. Passive coping strategies such as "I...

Field of Interest: Rheumatology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness